Search
Now showing items 1-20 of 519
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
Huetter-Kroenke, Marie-Luise et al. (2016)
Wissenschaftlicher Artikel
The European LeukemiaNet: achievements and perspectives
Hehlmann, Ruediger et al. (2011)
Wissenschaftlicher Artikel
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Dreger, Peter et al. (2012)
Wissenschaftlicher Artikel
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Döhner, Hartmut et al. (2014)
Wissenschaftlicher Artikel
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGV(H) gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia
Heintel, D et al. (2004)
Wissenschaftlicher Artikel
Results of a multicenter phase II trial for older patients with c-kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose ara-C and imatinib
Heidel, Florian et al. (2007)
Wissenschaftlicher Artikel
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia
Heintel, D et al. (2005)
Wissenschaftlicher Artikel
Acute Myeloid Leukemia
Döhner, Hartmut; Weisdorf, Daniel J.; Bloomfield, Clara D. (2015)
Wissenschaftlicher Artikel
Acute myeloid leukaemia
Estey, Elihu; Döhner, Hartmut (2006)
Wissenschaftlicher Artikel
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia
Kienle, Dirk et al. (2010)
Wissenschaftlicher Artikel
Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes
Kalla, C et al. (2005)
Wissenschaftlicher Artikel
Telomere length in mantle cell lymphoma
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Kampa-Schittenhelm, Kerstin Maria et al. (2013)
Wissenschaftlicher Artikel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Döhner, Hartmut et al. (2010)
Wissenschaftlicher Artikel
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy
Herling, Carmen Diana et al. (2016)
Wissenschaftlicher Artikel
MNI overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML
Heuser, Michael et al. (2007)
Wissenschaftlicher Artikel
High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis
Liebisch, P et al. (2003)
Wissenschaftlicher Artikel
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma
Liebisch, P et al. (2003)
Wissenschaftlicher Artikel
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
Greiner, J et al. (2004)
Wissenschaftlicher Artikel
Transient genetic labeling of human CD34-positive hematopoietic stem cells using nucleofection
Greiner, J et al. (2004)
Wissenschaftlicher Artikel